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Supplemental Figures
Figure S1 -Average methylation and methylation variability at variably methylated sites in TCGA tumors vs. controls. Probe density as a function of mean methylation and standard deviation in tumors vs. controls across cancer types. Densities were computed after discarding probes in chromosomes X and Y, as well as probes with low variance (we required SD<0.1). (A) Probe density as a function of mean methylation in tumors vs. controls across cancer types, for variably methylated probes located within CGIs. (B) Probe density as a function of standard deviation in tumors vs. controls across cancer types, for variably methylated probes located within CGIs. (C) Probe density as a function of mean methylation in tumors vs. controls across cancer types, for probes located in CGI shores and shelves. In all panels, color scale was normalized for each cancer type and ranges from dark blue (lowest density of probes) to dark red (highest density). The dotted white diagonal line represents equal values of average probe methylation in tumors and controls. Panels (A) and (B) show that, for most cancer types under consideration, there exists a set of variably methylated sites with very low levels of methylation in controls and widely varying levels of methylation across tumors. By contrast, panel (C) shows that probes located in CGI shores and shelves (i.e., in 2 kb flanking regions of CGIs and CGI shores, respectively) tend to exhibit high levels of methylation in controls and slightly decreased levels of methylation in tumors. More details about the way in which probe densities were computed and drawn are provided in Supplemental Methods 1. 
Figure S5 -Associations between CIMP status and clinical annotations in BRCA and HNSC. (A)
PAM50 molecular subgroups, ER status and HER status vs. CIMP status in BRCA. (B) Anatomic subdivision and recurrence free survival curves as a function of CIMP status in HNSC. All p-values correspond to Fisher's exact test for statistical associations and were corrected for multiple hypotheses using Bonferroni correction (except the p-value for the survival curve, which comes from a log-rank test and is shown uncorrected).
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Mixed Endo Probes that were associated to both gene promoters and gene bodies were excluded from the plots, so that the two probe sets are mutually exclusive. Color scale was normalized for each cancer type and ranges from dark blue (lowest density of probes) to dark red (highest density). The dotted white diagonal line represents equal values of average probe methylation in tumors and controls. 
